Np Thyroid 60 Tablet
NDC Package 51655-132-52

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

Np Thyroid 60 (levothyroxine, liothyronine) tablets is iNDICATIONS AND USAGE: NP Thyroid tablets (thyroid tablets, USP) are indicated: 1. This formulation utilizes a tablet delivery system. Marketed by Northwind Health Company, Llc, this product is identified by NDC 51655-132.

Identification & Billing

NDC Package Code
51655-132-52
Package Description
30 TABLET in 1 BOTTLE, DISPENSING
Product Code
11-Digit Billing Format
51655013252
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Np Thyroid 60
Non-Proprietary Name
Levothyroxine, Liothyronine
Substance Name
Levothyroxine; Liothyronine
Dosage Form
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route
Oral - Administration to or by way of the mouth.
Usage Information
INDICATIONS AND USAGE: NP Thyroid tablets (thyroid tablets, USP) are indicated: 1. As replacement or supplemental therapy in patients with hypothyroidism of any etiology, except transient hypothyroidism during the recovery phase of subacute thyroiditis. This category includes cretinism, myxedema, and ordinary hypothyroidism in patients of any age (children, adults, the elderly), or state (including pregnancy); primary hypothyroidism resulting from functional deficiency, primary atrophy, partial or total absence of thyroid gland, or the effects of surgery, radiation, or drugs, with or without the presence of goiter; and secondary (pituitary), or tertiary (hypothalamic) hypothyroidism (See WARNINGS). 2. As pituitary TSH suppressants, in the treatment or prevention of various types of euthyroid goiters, including thyroid nodules, subacute or chronic Iymphocytic thyroiditis (Hashimoto’s), multinodular goiter, and in the management of thyroid cancer. 3. As diagnostic agents in suppression tests to differentiate suspected mild hyperthyroidism or thyroid gland autonomy.

Regulatory & Marketing

Labeler Name
Northwind Health Company, Llc
Product Type
Human Prescription Drug
Marketing Category
UNAPPROVED DRUG OTHER - An unapproved drug product in a marketing category that is not reflected on a particular list.
Start Marketing Date
02-12-2015
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 51655-132-52 identifies a specific commercial package of 30 tablet in 1 bottle, dispensing of Np Thyroid 60, a human prescription drug labeled by Northwind Health Company, Llc. This tablet is formulated for oral use and contains levothyroxine; liothyronine as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Northwind Health Company, Llc on February 12, 2015. The current certification is valid through December 31, 2027.

How is this Northwind Health Company, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 51655013252. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
51655-132-52
11-Digit CMS (5-4-2)
51655-0132-52

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.